Tempus AI
$57.29
1518
-$1.08-1.85% Monday 21:00
Statistics
Day High
58.32
Day Low
55.85
52W High
104.32
52W Low
36.22
Volume
4,003,959
Avg. Volume
4,834,645
Mkt Cap
9.9B
P/E Ratio
41.79
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Jul 6
$0.44
Jul 6
$0.26
Jun 5
$0.23
Jun 4
$0.22
Jun 3
$0.2
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
24FebExpected
Expected EPS
-0.041441
Actual EPS
N/A
Financials
-107.63%Profit Margin
Unprofitable1.39BRevenue
-1.49BNet Income
Analyst Ratings
$86.44Average Price Target
The highest estimate is 105.00.
From 9 ratings within the last 6 months. This is not an investment recommendation.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy 78%
Hold 22%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TEM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Show more...
CEO
Mr. Eric P. Lefkofsky J.D.
Employees
2400
Country
US
ISIN
US88023B1035
Listings
0 Comments
Share your thoughts
FAQ
What is Tempus AI stock price today?▼
The current price of TEM is $57.29 USD — it has decreased by -1.85% in the past 24 hours. Watch Tempus AI stock price performance more closely on the chart.
What is Tempus AI stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tempus AI stocks are traded under the ticker TEM.
Is Tempus AI stock price growing?▼
TEM stock has risen by +9% compared to the previous week, the month change is a -12.29% fall, over the last year Tempus AI has showed a -17.65% decrease.
What is Tempus AI market cap?▼
Today Tempus AI has the market capitalization of 9.9B
What is Tempus AI revenue for the last year?▼
Tempus AI revenue for the last year amounts to 1.39B USD.
What is Tempus AI net income for the last year?▼
TEM net income for the last year is -1.49B USD.
Does Tempus AI pay dividends?▼
Yes, TEM dividends are paid annual. The last dividend per share was 0.44 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Tempus AI have?▼
As of February 24, 2026, the company has 2,400 employees.
In which sector is Tempus AI located?▼
Tempus AI operates in the Health Care sector.
When did Tempus AI complete a stock split?▼
Tempus AI has not had any recent stock splits.
Where is Tempus AI headquartered?▼
Tempus AI is headquartered in Chicago, US.